Teva Posts Q2 Loss, Cuts FY Revenues View; Reaches More Than $4 Bln Settlement Over Opioid Lawsuits
27/7 03:55
(RTTNews) - An Israel-based drug manufacturer Teva Pharmaceutical Industries Ltd. (TEVA) reported a loss in the second quarter compared to profit in the prior year. It reaffirmed its fiscal year 2022 earnings per share outlook, but cut annual revenues outlook mainly due to contin...